by Jordana Choucair | Oct 27, 2021 | Mental Health
Findings from the 2020 National Survey on Drug Use and Health (NSDUH) suggest that the COVID-19 pandemic had a negative impact on the nation’s well-being. Between October to December 2020, youths ages 12 to 17 who had a past-year major depressive episode (MDE)...
by Jordana Choucair | Oct 27, 2021 | Uncategorized
An FDA advisory committee endorsed a two-dose series of Pfizer-BioNTech’s COVID-19 vaccine for children ages 5- to 11-years-old. The committee found that the benefits of the shot outweighed the risks, voting 17-0 in favor with one abstention. If the FDA follows...
by Jordana Choucair | Oct 27, 2021 | D.C. News
Democrats are uniting around a plan to offer a few years of subsidized private insurance to low-income people in states that haven’t expanded Medicaid. The move is an effort to fill the coverage gap in those states that has been a major piece of the...
by Jordana Choucair | Oct 26, 2021 | Payers
Business groups are asking the White House to delay implementing President Joe Biden’s COVID-19 vaccine mandate. The National Retail Federation, the American Trucking Associations, and the Retail Industry Leaders Association asked officials to give businesses 90 days...
by Jordana Choucair | Oct 26, 2021 | Life Sciences
Moderna released trial results for its COVID-19 vaccine for children aged 6 to 11, saying it provides a “robust” immune response after two doses. The company said that two 50-microgram doses of the vaccine, half the dosage given to adults, produced...
Recent Comments